OWD
RDY icon

Osborn Williams & Donohoe’s Dr. Reddy's Laboratories RDY Stock Holding History

Osborn Williams & Donohoe’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,500
Closed -$12K – 578
2019
Q1 		$12K Buy
+1,500
New +$11.4K ﹤0.01% 614

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Osborn Williams & Donohoe's RDY Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Dr. Reddy's Laboratories (RDY) in Q2 2019, closing a stake of 1,500 shares — an estimated $12K sold.

Osborn Williams & Donohoe first reported a position in RDY in Q1 2019 and held it in 1 quarter. The position peaked at $12K in Q1 2019. 150 funds tracked by Wall St. Rank hold RDY as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Dr. Reddy's Laboratories position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 1,500 Dr. Reddy's Laboratories shares in Q2 2019, an estimated $12K.
  • Osborn Williams & Donohoe first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Dr. Reddy's Laboratories position peaked at $12K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.